Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The study aims to assess the effects of single dose and repeated weekly dosing of 50mg
d-cycloserine versus placebo on cognitive and memory functioning in schizophrenia patients.
The study will also examine the effects of 50mg d-cycloserine on positive symptoms and
negative symptoms, as well as assess tolerability and side-effects.